CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of early drug development software solutions, announced today that two Preclinical industry experts are joining the company and will be based out of a new Instem office in Bridgewater, New Jersey.

Jennifer Feldmann, formerly President of Xybion® will take on the newly created position of Vice President of Business Development when she joins Instem on February 1^st 2010, and will report directly to Phil Reason, Instem’s Chief Executive. Donna Danduone, formerly Xybion’s Professional Services Director and Quality Manager, has already taken on the role of Senior Consultant with Instem, having joined the company December 1^st 2009.

Phil Reason commented, “I’m absolutely delighted about Donna and Jennifer joining us. Each of them brings a unique set of skills from their many years at Xybion that dovetails perfectly with our ongoing initiatives for continuous innovation. Both Jennifer and Donna will be helping advance key strategic projects such as Instem business intelligence and data exchange solutions that are valuable to all drug development companies, no matter whose data collection software they use.”

Instem’s New Jersey office is located near several major Pharmaceutical clients and builds upon the successes of 2009 which included Instem adding 13 new customers and opening a full service office in Shanghai, China.

Jennifer said “I’ve long believed that a winning company in this industry will provide a solution that allows effective use of the enormous volume of data generated during drug development. While there are many good reasons for a company to retain specialized scientific data collection systems, a single solution for aggregation, exchange, and analysis of data is the key to the future. Instem has clearly been at the forefront in these areas and this is a fantastic opportunity to use my industry experience and relationships to promote this vision. I’m very pleased to be joining Instem’s exceptional team.”

Additionally, as clients make the transition from competitive Preclinical data acquisition solutions, particularly from Xybion, Jennifer and Donna will be very helpful to quickly highlight many of the value-added features and functions included within the Instem product suite.

Donna stated “In the current economic climate it’s very reassuring to join a company that is growing so successfully and continuing to invest heavily in its product development, sales, marketing and service delivery teams. I’m relishing the opportunity to be involved with the client selection and implementation of Instem’s Provantis solutions, and am particularly excited to be part of a focused team introducing Instem’s newer solutions. I have worked closely with Jennifer for 12 years and was very excited to hear that she will also be joining Instem.”

About Provantis™

Provantis™ is a modern, fully integrated software system for single users and global organizations engaged in preclinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, Provantis™ streamlines processes and workflows with straightforward, intuitive functionality for simple or complex studies within a GLP or non-GLP environment, on-site or over the Web.

About Instem®

Instem is a world-leading information solutions provider for the Life Sciences - accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products. In addition to highly focused departmental and scientific solutions, Instem provides a range of Business Intelligence, Planning, Workflow Management, Document Management and Report Compilation applications.

To learn more about Instem solutions and its mission, please visit www.instem.com

Xybion is a registered trademark of Xybion Medical Systems Corporation